Home » Spectrum Enters Co-Development, Commercialization Agreement
Spectrum Enters Co-Development, Commercialization Agreement
Spectrum Pharmaceuticals Inc. announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a
histone deacetylase inhibitor.
RTTNews
RTTNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May